Pulmonary arterial hypertension (PAH) is a progressive and fatal disorder. Despite the emergence of effective therapy, PAH is commonly advanced when recognized. One in 5 US patients diagnosed with PAH reported symptoms for >2 years before their disease was recognized. Younger individuals and patients with histories of common respiratory disorders were most likely to experience delayed PAH recognition.

Author : Brown LM et al.
Source : Chest
Read Full Article